Publisher
Springer Science and Business Media LLC
Subject
Otorhinolaryngology,Surgery
Reference15 articles.
1. Raut A, Huy NT (2021) Rising incidence of mucormycosis in patients with COVID-19: another challenge for India amidst the second wave? Lancet Respir Med 9(8):e77
2. L de HS, A A-I KV (2019) A Revised Species Concept for Opportunistic Mucor Species Reveals Species-Specific Antifungal Susceptibility Profiles. Antimicrob Agents Chemother 63(8):00653–00619
3. Honavar SG, Code, Mucor (2021) Guidelines for the diagnosis, staging and management of rhino-orbito-cerebral mucormycosis in the setting of COVID-19. Indian J Ophthalmol 69(6):1361–1365
4. Cornely OA, Alastruey-Izquierdo A, Arenz D, Chen SCA, Dannaoui E, Hochhegger B et al (2019) Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. Lancet Infect Dis 19(12):e405–e421
5. G SA, O L, Tj ER, Dp W (2012) K. Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis. ;54(June, Suppl. 1)
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献